Kenneth Lynard

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Pharming Group N.V. publishes a filing, an earnings call transcript or a press release.

Get PHAR alerts

About Kenneth Lynard

Kenneth Lynard is recorded as CFO at Pharming Group N.V. (PHAR). Kenneth Lynard has spoken on 2 earnings calls across 1 company, most recently for Pharming Group N.V. on July 30, 2026. Pharming Group N.V. is classified in the Biotechnology industry within the Healthcare sector.

Kenneth Lynard on recent calls

“I will now cover our Q2 and H1 2026 results along with our updated full year outlook. Q2 revenue was $90.2 million, down 3% year-on-year. Rukonez declined, as you heard earlier, by 10% versus Q2 of last year, and Joangia increased 40% year-on-year.”

CFO, Earnings conference call (announced in 6-K) · July 30, 2026

“As the new CFO, I'm excited to have joined Pharming at such an exciting time and have the opportunity to provide more color on our strong financial performance and outlook.”

CFO, Pharming Group N.V. Q3 FY2025 Earnings Call · September 30, 2025